Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00863395 · ClinicalTrials.gov registry record · Phase 1
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
A Phase 1 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00863395 is a Phase 1 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 6 participants.
The verdict
NCT00863395, a Phase 1 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to define the mechanisms that underlie the refractory pruritus (itch) in Cutaneous T-Cell Lymphoma (CTCL).
Interventions
- PROCEDURE skin biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00863395
The ClinicalTrials.gov registry entry for NCT00863395 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which skin biopsy is the first listed.
NCT00863395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00863395 about?
NCT00863395 is a clinical study titled "Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma". The purpose of this study is to define the mechanisms that underlie the refractory pruritus (itch) in Cutaneous T-Cell Lymphoma (CTCL).
What is the current status of trial NCT00863395?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00863395?
The interventions under investigation include: skin biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00863395?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.